Cargando…
Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate
The fifth most common cancer worldwide is hepatocellular carcinoma (HCC), which has an annual mortality rate of ~800,000. Although surgical procedures for HCC, such as hepatic resection and liver transplantation, have progressed and the outcomes of patients have improved, HCC is still characterized...
Autores principales: | Tao, Ran, Wang, Zhong-Feng, Qiu, Wei, He, Yu-Fang, Yan, Wei-Qun, Sun, Wen-Yi, Li, Hai-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450779/ https://www.ncbi.nlm.nih.gov/pubmed/28588665 http://dx.doi.org/10.3892/etm.2017.4294 |
Ejemplares similares
-
Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinate
por: LIU, BIN, et al.
Publicado: (2013) -
Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways
por: Naz, Faiza, et al.
Publicado: (2020) -
Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma
por: Yan, Jia, et al.
Publicado: (2023) -
Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin
por: Ma, Qixiang, et al.
Publicado: (2018) -
Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation
por: Zhang, Xue, et al.
Publicado: (2017)